Latest Share Chat

REMOVE ADS

YGEN.L Regulatory News (YGEN)

YGEN.L Information

There is currently no data for YGEN

REMOVE ADS

Suspension

15 Apr 2014 12:30

RNS Number : 8768E

ViaLogy PLC

15 April 2014

ViaLogy Plc

("Company")

Suspension

The Company notes the recent rise in its share price. The Company confirms that it is in discussions in relation to a possible transaction which, if completed, would constitute a reverse transaction pursuant to the AIM Rules. Consequently, the Company has requested that its shares are temporarily suspended with immediate effect, pending a further announcement.

Enquiries:

ViaLogy Plc

Mark Collingbourne

+44 1620 810 183

Cairn Financial Advisers LLP

Nomad

Liam Murray

Avi Robinson

+44 20 7148 7900

Panmure Gordon (UK) Limited

Broker

Robert Naylor

Freddy Crossley

+44 20 7886 2500

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUVAARSKASAAR

Date		Source	Headline
1st Apr 2019	12:12 pm	RNS	Holding(s) in Company
25th Mar 2019	7:00 am	RNS	Yourgene raises IONA® test awareness in Egypt
26th Feb 2019	3:21 pm	RNS	Holding(s) in Company
22nd Feb 2019	10:00 am	EQS	Hardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 2019	8:05 am	RNS	Holding(s) in Company
19th Feb 2019	2:21 pm	RNS	Holding(s) in Company
19th Feb 2019	7:15 am	EQS	Hardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 2019	10:59 am	RNS	Issue of Equity
18th Feb 2019	7:00 am	RNS	Major Capital & Commercial Restructuring
8th Jan 2019	7:00 am	RNS	Yourgene launches Sage 32 plex
3rd Dec 2018	7:00 am	RNS	Half-year Results
7th Nov 2018	7:00 am	RNS	Change of Name to Yourgene Health plc
5th Nov 2018	11:24 am	RNS	Share Transfer
2nd Nov 2018	7:00 am	RNS	Directorate Change
25th Oct 2018	3:30 pm	RNS	Result of AGM
25th Oct 2018	7:00 am	RNS	Holding(s) in Company
25th Oct 2018	7:00 am	RNS	AGM Statement
22nd Oct 2018	7:00 am	RNS	Further re: Fundraise
12th Oct 2018	1:15 pm	RNS	Availability of Research Commentary
12th Oct 2018	7:00 am	RNS	Trading Update and Notice of Results
5th Oct 2018	7:00 am	RNS	Director's dealing and share option issue
4th Oct 2018	7:00 am	RNS	$1 million collaboration agreement
3rd Oct 2018	7:00 am	RNS	Directorate change
2nd Oct 2018	7:00 am	RNS	Notice of AGM
1st Oct 2018	12:20 pm	RNS	Result of Fundraise
28th Sep 2018	5:41 pm	RNS	Proposed fundraise to raise approximately £2.5m
28th Sep 2018	5:40 pm	RNS	Full year results and half-year trading update
25th Sep 2018	11:31 am	RNS	Holding(s) in Company
21st Sep 2018	4:10 pm	RNS	Holding(s) in Company
21st Sep 2018	7:00 am	RNS	Holding(s) in Company
20th Sep 2018	9:30 am	RNS	Senior Appointment & Anticipated Director Change
19th Sep 2018	11:05 am	RNS	Second Price Monitoring Extn
19th Sep 2018	11:00 am	RNS	Price Monitoring Extension
19th Sep 2018	7:00 am	RNS	Legal Settlement & Licence Agreement with Illumina
11th Sep 2018	7:00 am	RNS	Holding(s) in Company
7th Aug 2018	10:57 am	RNS	Holding(s) in Company
12th Jul 2018	7:00 am	RNS	Share option awards
4th Jul 2018	7:00 am	RNS	Board Changes
26th Jun 2018	1:31 pm	RNS	Collaboration with Abnova
13th Jun 2018	7:00 am	RNS	Outstanding NIPS Solution Provider Award Win
11th Jun 2018	7:00 am	RNS	DNA sequencing technology development agreement
7th Jun 2018	3:44 pm	RNS	Holding(s) in Company
5th Jun 2018	7:00 am	RNS	Premaitha signs partnership agreement in India
4th Jun 2018	11:05 am	RNS	Holding(s) in Company
24th May 2018	7:00 am	RNS	Holding(s) in Company
18th May 2018	4:38 pm	RNS	Holding(s) in Company
18th May 2018	12:06 pm	RNS	Holding(s) in Company
18th May 2018	12:05 pm	RNS	Holding(s) in Company
18th May 2018	9:40 am	RNS	Holdings in Company
15th May 2018	7:00 am	RNS	Year-end Trading Update and £2.5m Fundraising

Latest Share Chat

YGEN.L Regulatory News (YGEN)

Suspension

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending